Abstract
A novel, rapid and a stability-indicating reverse phase LC method has been developed and validated for the simultaneous estimation of Clopidogrel and Aspirin in tablet dosage form. The chromatographic separation was achieved on a novel core shell technology phenyl hexyl stationary phase of particle size 2.6μ. The method employed a linear gradient elution and the detection wavelength was set at 220nm. The proposed method was extensively validated as per ICH guidelines. The specificity of the method was proved by performing forced degradation studies. Regression analysis shows r value (correlation coefficient) of greater than 0.999 for individual active drug substances. Accuracy was proved in the range of 50% to 150% of working range.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
